The 2019 NARSAD Young Investigator grantees from the Brain and Behavior Research Foundation include six faculty members from the Icahn School of Medicine at Mount Sinai. Their research aims are listed below. Jessica Ables, MD, PhD, seeks to determine the effect of...

Mount Sinai’s Partial Hospital Program provides an intensive level of psychiatric care for patients with acute symptoms—without hospitalization. The program treats patients with a range of psychiatric conditions, and places them on specialized tracks based on symptom...

This year’s American College of Neuropsychopharmacology (ACNP) conference takes place December 8-11 in Orlando, Florida. Faculty from the Department of Psychiatry will be contributing via the president’s plenary, panels, study groups, and posters. The schedule of...

On October 30, the Addiction Institute of Mount Sinai hosted a full day of lectures, posters, and discussions by prominent scientists, clinicians, and policymakers tackling addiction from all angles: across the lifespan, psychosocial, epidemiology, policy,...

In October 2018, the Addiction Institute of Mount Sinai (AIMS) announced its strategic alliance with Center on Addiction (CoA), formerly known as The National Center on Addiction and Substance Abuse or CASA. The alliance combines AIMS’ clinical expertise with CoA’s...

This year’s Mental Health Services Conference (IPS), put on by the American Psychiatric Association (APA), takes place October 2-6 at the Sheraton New York Times Square in Manhattan. This years' conference focuses on four core tracks: addiction psychiatry,...